Anti-NPC1/ NPC/ POGZ monoclonal antibody

Anti-NPC1/ NPC/ POGZ antibody for FACS & in-vivo assay

Target products collectionGo to NPC1/NPC1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0896-Ab-1/ GM-Tg-hg-MP0896-Ab-2Anti-Human NPC1 monoclonal antibodyHuman
GM-Tg-rg-MP0896-Ab-1/ GM-Tg-rg-MP0896-Ab-2Anti-Rat NPC1 monoclonal antibodyRat
GM-Tg-mg-MP0896-Ab-1/ GM-Tg-mg-MP0896-Ab-2Anti-Mouse NPC1 monoclonal antibodyMouse
GM-Tg-cynog-MP0896-Ab-1/ GM-Tg-cynog-MP0896-Ab-2Anti-Cynomolgus/ Rhesus macaque NPC1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0896-Ab-1/ GM-Tg-felg-MP0896-Ab-2Anti-Feline NPC1 monoclonal antibodyFeline
GM-Tg-cang-MP0896-Ab-1/ GM-Tg-cang-MP0896-Ab-2Anti-Canine NPC1 monoclonal antibodyCanine
GM-Tg-bovg-MP0896-Ab-1/ GM-Tg-bovg-MP0896-Ab-2Anti-Bovine NPC1 monoclonal antibodyBovine
GM-Tg-equg-MP0896-Ab-1/ GM-Tg-equg-MP0896-Ab-2Anti-Equine NPC1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0896-Ab-1/ GM-Tg-hg-MP0896-Ab-2; GM-Tg-rg-MP0896-Ab-1/ GM-Tg-rg-MP0896-Ab-2;
GM-Tg-mg-MP0896-Ab-1/ GM-Tg-mg-MP0896-Ab-2; GM-Tg-cynog-MP0896-Ab-1/ GM-Tg-cynog-MP0896-Ab-2;
GM-Tg-felg-MP0896-Ab-1/ GM-Tg-felg-MP0896-Ab-2; GM-Tg-cang-MP0896-Ab-1/ GM-Tg-cang-MP0896-Ab-2;
GM-Tg-bovg-MP0896-Ab-1/ GM-Tg-bovg-MP0896-Ab-2; GM-Tg-equg-MP0896-Ab-1/ GM-Tg-equg-MP0896-Ab-2
Products NameAnti-NPC1 monoclonal antibody
Formatmab
Target NameNPC1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-NPC1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species NPC1/ NPC/ POGZ VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLV000454human NPC1 Lentivirus particle
    ORF Viral VectorpGMLV000463human NPC1 Lentivirus plasmid
    ORF Viral VectorpGMLV000454human NPC1 Lentivirus plasmid
    ORF Viral VectorvGMLV000463human NPC1 Lentivirus particle


    Target information

    Target IDGM-MP0896
    Target NameNPC1
    Gene ID4864,18145,266732,700835,403698,493693,286772,100059175
    Gene Symbol and SynonymsA430089E03Rik,Cdig2,D18Ertd139e,D18Ertd723e,lcsd,nmf164,NPC,NPC1,POGZ,SLC65A1,SLC66A1,spm
    Uniprot AccessionO15118
    Uniprot Entry NameNPC1_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000141458
    Target ClassificationN/A

    The target: NPC1, gene name: NPC1, also named as NPC, POGZ, SLC65A1. This gene encodes a large protein that resides in the limiting membrane of endosomes and lysosomes and mediates intracellular cholesterol trafficking via binding of cholesterol to its N-terminal domain. It is predicted to have a cytoplasmic C-terminus, 13 transmembrane domains, and 3 large loops in the lumen of the endosome - the last loop being at the N-terminus. This protein transports low-density lipoproteins to late endosomal/lysosomal compartments where they are hydrolized and released as free cholesterol. Defects in this gene cause Niemann-Pick type C disease, a rare autosomal recessive neurodegenerative disorder characterized by over accumulation of cholesterol and glycosphingolipids in late endosomal/lysosomal compartments.[provided by RefSeq, Aug 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.